Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-sjtt6 Total loading time: 0 Render date: 2024-06-21T12:29:43.982Z Has data issue: false hasContentIssue false

16 - Bone health in women with epilepsy

from Part IV - Health challenges for women with epilepsy

Published online by Cambridge University Press:  02 November 2009

By
Robert Marcus
Edited by
Martha J. Morrell  and
Kerry L. Flynn
Robert Marcus
Affiliation:
VA Palo Alto Health Care, 3801 Miranda Avenue, Palo Alto, CA 94304, USA
Martha J. Morrell
Affiliation:
Columbia University, New York
Kerry L. Flynn
Affiliation:
Columbia-Presbyterian Cancer Center, New York
Get access

Summary

Women are at greater risk for osteoporosis than men. For some years, physicians have been concerned that women with epilepsy are at particular risk for this condition, which is associated with bone fractures. Osteoporosis (thinning of the bones) may be caused by some antiepileptic drugs. Unfortunately, the available scientific information cannot tell health-care providers which medications cause bone disease and which of the drugs may be safer to use.

Dr Robert Marcus is a bone specialist who is an expert in bone health in women with epilepsy. He is a former Professor of Internal Medicine and Endocrinology at Stanford University. We have collaborated in a study evaluating bone density and bone turnover in women with epilepsy. This study, when it is complete, promises to provide helpful information about the effect of particular antiepileptic drugs on bone.

In the meantime, we recommend that all women with epilepsy employ good bone health practices; that is, regular, gravity-resisting exercise, good nutrition, and adequate calcium and vitamin D intake. Women with epilepsy should also have their bone density checked at least at menopause, if not earlier. More bone health recommendations will come out of the research being conducted.

MJM

Some people with epilepsy have an increased risk for a condition of the skeleton called osteoporosis. The purpose of this chapter is to clarify the nature of this relationship, to outline its possible causes, and to discuss current approaches to treatment.

Keywords

antiepileptic medicationsbone acquisitionbone healthepilepsyosteoporosismenopausal women
Type
Chapter
Information
Women with Epilepsy
A Handbook of Health and Treatment Issues
 , pp. 164 - 170
Publisher: Cambridge University Press
Print publication year: 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Boglium, G, Beghi, E, Crespi, V. Anticonvulsant drugs and bone metabolism. Acta Neurol Scand 1986; 74:284–8CrossRefGoogle Scholar
Chung, S, Ahn, C.Effects of anti-epileptic drug therapy on bone mineral density in ambulatory epileptic children. Brain Dev 1994; 16:382–5CrossRefGoogle Scholar
Collins, N, Maher, J, Cole, M. A prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium, and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalacia. Q J Med 1991; 78:113–22Google ScholarPubMed
Cummings, SR, Nevitt, MC, Browner, WS. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1995; 332(12):767–73CrossRefGoogle ScholarPubMed
Gough, H, Goggin, T, Bissessar, A. A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in outpatients with epilepsy. Q J Med 1986; 230:569–77Google Scholar
Sheth, RD, Wesolowski, CA, Jacob, JC. Effect of carbamazepine and valproate on bone mineral density. J Pediatr 1995; 127:256–62CrossRefGoogle ScholarPubMed
Stephen, LJ, McLellan, AR, Harrison, JH. Bone density and antiepileptic drugs: a case controlled study. Seizure 1999; 8(6):339–42CrossRefGoogle ScholarPubMed
Valimaki, MJ, Tiihonen, M, Laitinen, K. Bone mineral density measured by dual-energy X-ray absorptiometry and novel markers of bone formation and resorption in patients on anti-epileptic drugs. J Bone Miner Res 1994; 9:631–7CrossRefGoogle Scholar
Verrotti, A, Freco, R, Morgese, G. Increased bone turnover in epileptic patients treated with carbamazepine. Ann Neurol 2000; 47:385–83.0.CO;2-W>CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×